Current concepts in ablative procedures for primary benign liver lesions: a step forward to minimize the invasiveness of treatment when deemed necessary

被引:0
作者
Aldo Carnevale
Fabio Pellegrino
Alberto Cossu
Anna Maria Ierardi
Gian Carlo Parenti
Gianpaolo Carrafiello
Melchiore Giganti
机构
[1] Arcispedale Sant’Anna,University Radiology Unit, Radiology Department
[2] University of Ferrara,Department of Morphology, Surgery and Experimental Medicine, Radiology Section
[3] University of Milan,Diagnostic and Interventional Radiology Department, ASST Santi Paolo E Carlo, San Paolo Hospital
[4] Ospedale Civile Santa Maria Delle Croci,Department of Diagnostic Imaging of Romagna
来源
Medical Oncology | 2020年 / 37卷
关键词
Benign tumors; Liver; Ablation; Hepatic hemangioma; Hepatocellular adenoma;
D O I
暂无
中图分类号
学科分类号
摘要
With increased use of medical imaging, the incidental detection of benign solid liver tumors has become more frequent. Facing with benign disease, the indications for surgery are still object of discussion in light of the stable natural course of most lesions and obvious drawbacks of any surgical intervention; therefore, in most situations, a conservative approach is recommended, and surgery is mainly reserved for those cases with persistent or worsening symptoms, or who are at risk for complications as malignant transformation. The advent of ablative techniques has widened the range of treatment options available to these patients, presenting as a valid alternative to resection in terms of safety and efficacy in selected cases, particularly in patients who are considered poor surgical candidates and with smaller lesions. This review outlines the role of percutaneous ablative methods for benign solid liver tumors that are encountered in adults, providing a per histology analysis of the existing evidence. The up-to-date strategies for management of the most common benign solid tumors are recapitulated.
引用
收藏
相关论文
共 193 条
[21]  
Moher D(2019)The value of 3D visualization operative planning system in ultrasound-guided percutaneous microwave ablation for large hepatic hemangiomas: a clinical comparative study BMC Cancer BMC Cancer 19 1-9
[22]  
Liberati A(2018)Risk factors of haemoglobinuria after microwave ablation of liver tumours Clin Radiol 73 982.e9-982.e15
[23]  
Tetzlaff J(2011)Symptomatic-enlarging hepatic hemangiomas are effectively treated by percutaneous ultrasonography-guided radiofrequency ablation J Hepatol 54 559-565
[24]  
Altman DG(2019)Outcomes of ultrasound-guided percutaneous microwave ablation versus surgical resection for symptomatic large hepatic hemangiomas Int J Hyperthermia Taylor & Francis 36 632-639
[25]  
Rhim H(2018)Selecting a suitable surgical treatment for hepatic angiomyolipoma: a retrospective analysis of 92 cases ANZ J Surg 88 E664-E669
[26]  
Lim HK(2014)Genomic profiling of hepatocellular adenomas reveals recurrent FRK-activating mutations and the mechanisms of malignant transformation Cancer Cell 25 428-441
[27]  
Kim Y(2012)Systematic review of haemorrhage and rupture of hepatocellular adenomas Br J Surg 99 911-916
[28]  
Choi D(2015)Management of hepatocellular adenoma: recent advances Clin Gastroenterol Hepatol 13 1221-1230
[29]  
Van Vledder MG(2014)Resection, transplantation and local regional therapies for liver adenomas Expert Rev Gastroenterol Hepatol 8 803-810
[30]  
Van Aalten SM(2009)A single-center surgical experience of 122 patients with single and multiple hepatocellular adenomas Gastroenterology 137 1698-1705